Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials

OBJECTIVES: This meta-analysis assessed the efficacy and safety of novel β-lactam/β-lactamase inhibitor combinations in the treatment of complicated urinary tract infection (cUTI)/acute pyelonephritis (APN). METHODS: PubMed, Web of Science, EBSCO (Elton B. Stephens Co.), Cochrane Library, Ovid MEDLI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Li-Chin, Lai, Chih-Cheng, Chang, Shen-Peng, Lan, Shao-Huan, Hung, Shun-Hsing, Lin, Wei-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220034/
https://www.ncbi.nlm.nih.gov/pubmed/32384444
http://dx.doi.org/10.1097/MD.0000000000019960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220034/
https://www.ncbi.nlm.nih.gov/pubmed/32384444
http://dx.doi.org/10.1097/MD.0000000000019960

Ejemplares similares